Role of CD152 genetic polymorphisms in the susceptibility to breast cancer
- PMID: 28416762
- PMCID: PMC5432289
- DOI: 10.18632/oncotarget.15794
Role of CD152 genetic polymorphisms in the susceptibility to breast cancer
Abstract
Background: The polymorphisms in cluster of differentiation 152 (CD152) gene have been reported to be associated with breast cancer (BC), but relevant findings were far from conclusive. Therefore, we carried out this meta-analysis to combine those results for a clearer perspective on this issue.
Results: In our meta-analysis, a total of 8 eligible publications of 19 case-control studies were selected, which totally contained 7,442 BC cases and 7,376 normal controls. Among the five polymorphisms of CD152 gene, +49 G/A, -1661 A/G and -318 C/T significantly increased the risk of BC under corresponding genetic comparisons; while CT60 G/A polymorphism was negatively related to the cancer susceptibility. In addition, -1772 T/C polymorphism of CD152 gene was not associated with the development of BC.
Materials and methods: Online databases and other sources were searched for published studies on the relationship between BC susceptibility and CD152 polymorphisms (+49 G/A, -1661 A/G, -1722 T/C, -318 C/T and CT60 G/A). The strength of association was evaluated with pooled odds ratios (ORs) and their corresponding 95% confidence intervals (95% CIs). Heterogeneity evaluation was conducted via Q test. Sensitivity analysis was used to detect the stability of our results. Begg's funnel plot and Egger's test were applied to investigate publication bias among selected studies.
Conclusions: The polymorphisms +49 G/A, -1661 A/G and -318 C/T may elevate the susceptibility to BC, but the polymorphism CT60 G/A may offer protection against the cancer.
Keywords: CD152; CTLA-4; breast cancer; immune response; polymorphisms.
Conflict of interest statement
None.
Figures




Similar articles
-
Impacts of CD152 polymorphisms on cervical cancer susceptibility.Pathol Res Pract. 2020 Aug;216(8):152918. doi: 10.1016/j.prp.2020.152918. Epub 2020 Mar 9. Pathol Res Pract. 2020. PMID: 32616425
-
Cytotoxic T-lymphocyte antigen 4 polymorphisms and breast cancer susceptibility: Evidence from a meta-analysis.J Chin Med Assoc. 2023 Feb 1;86(2):207-219. doi: 10.1097/JCMA.0000000000000851. Epub 2023 Jan 18. J Chin Med Assoc. 2023. PMID: 36652567
-
CTLA-4 and MDR1 polymorphisms increase the risk for ulcerative colitis: A meta-analysis.World J Gastroenterol. 2015 Sep 14;21(34):10025-40. doi: 10.3748/wjg.v21.i34.10025. World J Gastroenterol. 2015. PMID: 26379408 Free PMC article. Review.
-
Do polymorphisms in protein kinase catalytic subunit alpha-1 gene associated with cancer susceptibility? a meta-analysis and systematic review.BMC Med Genet. 2018 Oct 19;19(1):189. doi: 10.1186/s12881-018-0704-8. BMC Med Genet. 2018. PMID: 30340465 Free PMC article.
-
The FGFR2 Variant rs13387042 is Associated With Breast Cancer Risk: A Meta-Analysis and Systematic Review.Clin Breast Cancer. 2024 Aug;24(6):552-561. doi: 10.1016/j.clbc.2024.03.009. Epub 2024 Mar 15. Clin Breast Cancer. 2024. PMID: 38641470
Cited by
-
Immune Checkpoint Molecules-Inherited Variations as Markers for Cancer Risk.Front Immunol. 2021 Jan 14;11:606721. doi: 10.3389/fimmu.2020.606721. eCollection 2020. Front Immunol. 2021. PMID: 33519815 Free PMC article. Review.
-
Association between CTLA-4 + 49A > G and - 318C > T single-nucleotide polymorphisms and susceptibility to thyroid neoplasm.Endocrine. 2018 Oct;62(1):159-165. doi: 10.1007/s12020-018-1663-8. Epub 2018 Aug 4. Endocrine. 2018. PMID: 30078171
-
Correlation between JAK2, STAT3, and CTLA4 Relative Gene Expressions and Oral Squamous Cell Carcinoma.J Dent (Shiraz). 2025 Mar 1;26(1):25-32. doi: 10.30476/dentjods.2024.100237.2205. eCollection 2025 Mar. J Dent (Shiraz). 2025. PMID: 40092547 Free PMC article.
References
-
- Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87–108. - PubMed
-
- DeSantis C, Ma J, Bryan L, Jemal A. Breast cancer statistics, 2013. CA Cancer J Clin. 2014;64:52–62. - PubMed
-
- Hery C, Ferlay J, Boniol M, Autier P. Changes in breast cancer incidence and mortality in middle-aged and elderly women in 28 countries with Caucasian majority populations. Annals of oncology. 2008;19:1009–1018. - PubMed
-
- Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90. - PubMed
-
- Ban KA, Godellas CV. Epidemiology of breast cancer. Surgical oncology clinics of North America. 2014;23:409–422. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical